ALBIREO
Albireo AB c/o AstraZeneca AB, Legal Dept.
Application Filed: 2007-11-06
Trademark Application Details
IR CANCELLED; US APPLICATION ABANDONED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79046388 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | H |
| Domestic Representative | K&L GATES LLP |
| Attorney Name | Mark I. Peroff |
| Attorney Docket Number | 0820329.0004 |
| Law Office Assigned | M50 |
| Employee Name | VERHOSEK, WILLIAM T |
Timeline
| 2007-11-06 | Application Filed |
| 2010-07-09 | Location: TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED |
| 2017-11-07 | Abandon |
| 2017-11-07 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Albireo AB c/o AstraZeneca AB, Legal Dept. |
| Address | Arvid Wallgrens Backe 20 SE-413 46 GÃTEBOR SE |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | SE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for human use in the prevention and treatment of gynaecological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders, hepatico- pancreatico biliary- diseases, musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological disorders and diseases; ophthalmologic preparations; tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; skin and tissue repair and smoking cessation; Sanitary preparations for medical purposes; Veterinary pharmaceutical preparations for the prevention and treatment of gynaccological diseases and disorders, cardiovascular including dyslipidemia, atherosclerosis and cholesterol lowering diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders; hepatico- pancreatico- biliary- diseases, musculoskeletal diseases and disorders; pain, inflammation and inflammatory diseases and disorders; autoimmune diseases, metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral, parasitic and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction, haemolytic diseases and disorders; oncological and malignant diseases and disorders; postoperative adhesions; bone diseases and disorders; ophthalmologic disorders and diseases; dermatological disorders and diseases; ophthalmologic preparations; tooth decay, gingivitis, halitosis and periodontal disease; skin and tissue repair; all of the foregoing for treating felines, canines, bovines, porcines, equines, llamas, rabbits, rodents, birds, ferrets, poultry, goats and sheep |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2007-12-13 | 1 REPR M: |
| NEW APPLICATION ENTERED IN TRAM | 2007-12-14 | 2 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2008-02-20 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2008-02-21 | 4 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2008-02-22 | 5 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2008-02-22 | 6 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2008-02-23 | 7 RFCS P: |
| REFUSAL PROCESSED BY IB | 2008-03-14 | 8 RFNT P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2008-04-10 | 9 CHLD M: |
| PAPER RECEIVED | 2008-08-14 | 10 MAIL I:Incoming Correspondence |
| ASSIGNED TO LIE | 2008-08-20 | 11 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2008-08-20 | 12 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2008-08-20 | 13 ACEC I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2008-08-27 | 14 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2008-08-27 | 15 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2008-08-27 | 16 GNRN O:Outgoing Correspondence |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2008-12-13 | 17 ADCH M: |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-01-14 | 18 TCCA I:Incoming Correspondence |
| PAPER RECEIVED | 2009-02-27 | 19 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-03-03 | 20 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2009-03-03 | 21 ACEC I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2009-03-11 | 22 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2009-03-11 | 23 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2009-03-11 | 24 GNRN O:Outgoing Correspondence |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2009-05-14 | 25 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2009-05-14 | 26 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2009-08-06 | 27 OPNX P: |
| PAPER RECEIVED | 2009-09-11 | 28 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-09-16 | 29 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2009-09-16 | 30 ACEC I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2009-09-17 | 31 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2009-09-17 | 32 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2009-09-17 | 33 GNS3 O:Outgoing Correspondence |
| FINAL REFUSAL WRITTEN | 2009-12-04 | 34 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2009-12-04 | 35 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2009-12-04 | 36 GNFN O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2010-07-09 | 37 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2010-07-09 | 38 MAB2 O:Outgoing Correspondence |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2011-07-09 | 39 FICR P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2011-07-11 | 40 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2011-07-30 | 41 FINT P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2013-03-22 | 42 NREP P: |
| DEATH OF INTERNATIONAL REGISTRATION | 2018-06-01 | 43 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | 2018-06-02 | 44 DENA E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 